Picture of Alnylam Pharmaceuticals logo

ALNY Alnylam Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapFalling Star

Annual balance sheet for Alnylam Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments1,5361,8742,4362,1922,439
Net Total Accounts Receivable
Net Total Receivables43602199238328
Total Inventory
Prepaid Expenses
Total Current Assets1,7162,6152,8092,6922,983
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment646707734739726
Other Long Term Assets
Total Assets2,3953,4073,6433,5463,830
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities353585696768968
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities9562,3913,0553,7054,051
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity1,4391,016588-158-221
Total Liabilities & Shareholders' Equity2,3953,4073,6433,5463,830
Total Common Shares Outstanding